Karabelas Argeris N
SEC-identified person · CIK 1191229 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Regenxbio Inc. RGNX | Director | filed 2015 - 2026 |
| Valeant Pharmaceuticals International, Inc. vrx | Director | filed 2016 - 2022 |
| Rocket Pharmaceuticals, INC. RCKT | Director | filed 2015 - 2015 |
| Human Genome Sciences INC HGSI | Director · Chairman | filed 2006 - 2012 |
| Vanda Pharmaceuticals Inc. VNDA | Director · Chairman of the Board | filed 2006 - 2011 |
| Biodelivery Sciences International INC BDSI | Officer | filed 2006 - 2009 |
| Nitromed INC NTMD | Director · Chairman, Interim CEO & Pres. | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.